Movement Alert｜MicroPort Scientific Rises 5.11% in Regular Trading, Stock Recovers After Market Digests Orthopedics Divestiture Plan

Market Focus07-20

On July 20, MicroPort Scientific rose 5.11% in regular trading, trading at HKD 6.99, with turnover of HKD 99.37 million. The rebound follows a sharp 6.74% sell-off on July 17 triggered by market divergence over the company's proposed sale of its orthopedics business.

On July 15, the company announced that its subsidiary Suzhou MicroPort Orthopedics signed a letter of intent with Tinavi Medical Technologies to sell an 82.29% stake in Shanghai MicroPort Orthopedics, with consideration to be paid through issuance of new Tinavi shares. Shanghai MicroPort Orthopedics operates the group's international hip and knee reconstruction business across the US, Japan, and Europe, with its flagship medial pivot knee product exceeding one million global implants.

The current recovery likely reflects renewed market acceptance of the rationale to divest a financially pressured segment and refocus on core businesses. However, the transaction remains in the planning stage, subject to due diligence, definitive agreements, and regulatory approvals, with material uncertainty regarding completion.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187996050?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-20 15:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187996050","market":"hk","top_or_hot":-1,"title":"Movement Alert｜MicroPort Scientific Rises 5.11% in Regular Trading, Stock Recovers After Market Digests Orthopedics Divestiture Plan","media":"Market Focus","content":"<p><p>On July 20, MicroPort Scientific rose 5.11% in regular trading, trading at HKD 6.99, with turnover of HKD 99.37 million. The rebound follows a sharp 6.74% sell-off on July 17 triggered by market divergence over the company's proposed sale of its orthopedics business.</p><p>On July 15, the company announced that its subsidiary Suzhou MicroPort Orthopedics signed a letter of intent with Tinavi Medical Technologies to sell an 82.29% stake in Shanghai MicroPort Orthopedics, with consideration to be paid through issuance of new Tinavi shares. Shanghai MicroPort Orthopedics operates the group's international hip and knee reconstruction business across the US, Japan, and Europe, with its flagship medial pivot knee product exceeding one million global implants.</p><p>The current recovery likely reflects renewed market acceptance of the rationale to divest a financially pressured segment and refocus on core businesses. However, the transaction remains in the planning stage, subject to due diligence, definitive agreements, and regulatory approvals, with material uncertainty regarding completion.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜MicroPort Scientific Rises 5.11% in Regular Trading, Stock Recovers After Market Digests Orthopedics Divestiture Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜MicroPort Scientific Rises 5.11% in Regular Trading, Stock Recovers After Market Digests Orthopedics Divestiture Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-20 15:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 20, MicroPort Scientific rose 5.11% in regular trading, trading at HKD 6.99, with turnover of HKD 99.37 million. The rebound follows a sharp 6.74% sell-off on July 17 triggered by market divergence over the company's proposed sale of its orthopedics business.</p><p>On July 15, the company announced that its subsidiary Suzhou MicroPort Orthopedics signed a letter of intent with Tinavi Medical Technologies to sell an 82.29% stake in Shanghai MicroPort Orthopedics, with consideration to be paid through issuance of new Tinavi shares. Shanghai MicroPort Orthopedics operates the group's international hip and knee reconstruction business across the US, Japan, and Europe, with its flagship medial pivot knee product exceeding one million global implants.</p><p>The current recovery likely reflects renewed market acceptance of the rationale to divest a financially pressured segment and refocus on core businesses. However, the transaction remains in the planning stage, subject to due diligence, definitive agreements, and regulatory approvals, with material uncertainty regarding completion.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00853","symbol_name":"微创医疗","start_time":0,"source_url":"","article_id":"1187996050","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187996050","pubTimestamp":1784531233,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 20, MicroPort Scientific rose 5.11% in regular trading, trading at HKD 6.99, with turnover of HKD 99.37 million. The rebound follows a sharp 6.74% sell-off on July 17 triggered by market...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00853":"微创医疗"},"translate_title":"走势提醒|微创科技常规交易上涨5.11%，市场消化骨科剥离计划后股价回升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00853":1},"content_text":"On July 20, MicroPort Scientific rose 5.11% in regular trading, trading at HKD 6.99, with turnover of HKD 99.37 million. The rebound follows a sharp 6.74% sell-off on July 17 triggered by market divergence over the company's proposed sale of its orthopedics business.On July 15, the company announced that its subsidiary Suzhou MicroPort Orthopedics signed a letter of intent with Tinavi Medical Technologies to sell an 82.29% stake in Shanghai MicroPort Orthopedics, with consideration to be paid through issuance of new Tinavi shares. Shanghai MicroPort Orthopedics operates the group's international hip and knee reconstruction business across the US, Japan, and Europe, with its flagship medial pivot knee product exceeding one million global implants.The current recovery likely reflects renewed market acceptance of the rationale to divest a financially pressured segment and refocus on core businesses. However, the transaction remains in the planning stage, subject to due diligence, definitive agreements, and regulatory approvals, with material uncertainty regarding completion.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187996050","isCrawlerRequest":true}